Sanofi India Limited has announced that its Board of Directors will convene on April 28, 2026. The primary objective of the meeting is to review and approve the unaudited financial results for the quarter ended March 31, 2026. In accordance with internal compliance policies, the company has also initiated a temporary closure of its trading window to manage market disclosures effectively.
Upcoming Board Meeting Details
The management of Sanofi India Limited has scheduled a board meeting for Tuesday, April 28, 2026. During this session, the directors will evaluate the company’s financial performance for the quarter ending March 31, 2026. This periodic review is a critical component of the company’s commitment to financial transparency and stakeholder communication.
Trading Window Closure
To ensure compliance and maintain market integrity ahead of the announcement of these financial results, the company has implemented a trading window restriction. The trading window, which governs the buying and selling of company shares by designated persons, will remain closed from Wednesday, April 1, 2026, through Thursday, April 30, 2026. This closure period covers both the dates of the financial results announcement and the preceding period, ensuring that all trading activities remain aligned with the release of sensitive financial data.
Source: BSE
